respiratory syncytial vaccine

GSK’s Arexvy Vaccine Poised for Blockbuster Sales, Besting Pfizer in RSV Market Debut

Pfizer is facing not only a decline in its COVID-19 vaccine sales but also stiff competition from GSK in the ...